HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancerEdward J. Jarman, Simon P. Langdon|Breast Cancer Research|2019Cited by 69
Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptorsDavid H. Wilson, Luke Boulter, Deborah J. Henderson et al.|Nature Communications|2020Cited by 47
<scp>DKK1</scp> drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with <scp>anti‐DKK1</scp> therapeutic <scp>DKN</scp> ‐01Edward J. Jarman, Luke Boulter, Marta Horcas‐Lopez et al.|Liver International|2022Cited by 20
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver diseaseScott H. Waddell, Luke Boulter, Yuelin Yao et al.|Science Translational Medicine|2023Cited by 20
<i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Cancer Research|2022Cited by 17